Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
D
Show more
Class 5: Pharmaceutical preparations for the treatment of degenerative disorders and diseases, ocular disorders and diseases, and cancer; small molecule therapies, namely, pharmaceutical preparations, for the treatment of degenerative disorders and diseases, ocular disorders and diseases, and cancer
Class 42: Pharmaceutical research and products development of pharmaceuticals for the treatment of degenerative disorders and diseases, ocular disorders and diseases, and cancer; product, scientific, and pharmaceutical research and development in the field of small molecule therapeutics; scientific research for medical purposes in the field of degenerative disorders and diseases, ocular disorders and diseases, and cancer; medical and scientific research in the field of pharmaceuticals
Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 2 Feb 2021Application filedNew Application Entered
- 18 Aug 2021Assigned to an examining attorneyAssigned To Examiner
- 23 Aug 2021Office action issuedNon-Final Action Written
- 15 Feb 2022Response to office action filedTeas Response To Office Action Received
- 16 Feb 2022Approved for publicationApproved For Pub - Principal Register
- 22 Mar 2022Published for oppositionPublished For Opposition
- 17 May 2022Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 15 Nov 2022Statement-of-use extension 1 grantedSou Extension 1 Granted
- 15 May 2023Statement-of-use extension 2 grantedSou Extension 2 Granted
- 20 Oct 2023Statement-of-use extension 3 grantedSou Extension 3 Granted
- 10 Sep 2024Statement of use filedTeas Statement Of Use Received
- 12 Nov 2024Statement of use acceptedAllowed Principal Register - Sou Accepted
- 3 Dec 2024Registered on the Principal RegisterRegistered-Principal Register
All 38 events
| 2024-12-03 | Registered-Principal Register |
| 2024-12-03 | Notice Of Registration Confirmation Emailed |
| 2024-11-12 | Case Assigned To Intent To Use Paralegal |
| 2024-11-12 | Statement Of Use Processing Complete |
| 2024-11-12 | Allowed Principal Register - Sou Accepted |
| 2024-11-12 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2024-09-10 | Teas Statement Of Use Received |
| 2024-09-10 | Use Amendment Filed |
| 2024-04-30 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-04-29 | Sou Teas Extension Received |
| 2024-04-29 | Sou Extension 4 Filed |
| 2024-04-29 | Sou Extension 4 Granted |
| 2023-10-24 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-10-20 | Sou Teas Extension Received |
| 2023-10-20 | Sou Extension 3 Filed |
| 2023-10-20 | Sou Extension 3 Granted |
| 2023-05-17 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-05-15 | Sou Teas Extension Received |
| 2023-05-15 | Sou Extension 2 Filed |
| 2023-05-15 | Sou Extension 2 Granted |
| 2022-11-17 | Notice Of Approval Of Extension Request E-Mailed |
| 2022-11-15 | Sou Teas Extension Received |
| 2022-11-15 | Sou Extension 1 Filed |
| 2022-11-15 | Sou Extension 1 Granted |
| 2022-05-17 | Noa Mailed - Sou Required From Applicant |
| 2022-03-22 | Published For Opposition |
| 2022-03-22 | Official Gazette Publication Confirmation E-Mailed |
| 2022-03-02 | Notification Of Notice Of Publication E-Mailed |
| 2022-02-16 | Teas/Email Correspondence Entered |
| 2022-02-16 | Approved For Pub - Principal Register |
| 2022-02-15 | Teas Response To Office Action Received |
| 2022-02-15 | Correspondence Received In Law Office |
| 2021-08-23 | Non-Final Action Written |
| 2021-08-23 | Non-Final Action E-Mailed |
| 2021-08-23 | Notification Of Non-Final Action E-Mailed |
| 2021-08-18 | Assigned To Examiner |
| 2021-05-01 | New Application Office Supplied Data Entered |
| 2021-02-02 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of degenerative disorders and diseases, ocular disorders and diseases, and cancer; small molecule therapies, namely, pharmaceutical preparations, for the treatment of degenerative disorders and diseases, ocular disorders and diseases, and cancer
First use anywhere 5 Aug 2024 · First use in commerce 5 Aug 2024
Class 42 Technology & SaaS
Pharmaceutical research and products development of pharmaceuticals for the treatment of degenerative disorders and diseases, ocular disorders and diseases, and cancer; product, scientific, and pharmaceutical research and development in the field of small molecule therapeutics; scientific research for medical purposes in the field of degenerative disorders and diseases, ocular disorders and diseases, and cancer; medical and scientific research in the field of pharmaceuticals
First use anywhere 4 Mar 2021 · First use in commerce 4 Mar 2021
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 3 Dec 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.